Lipid raft-dependent and -independent signaling through HLEA-DR molecules

被引:59
作者
Bouillon, M
El Fakhry, Y
Girouard, J
Khalil, H
Thibodeau, J
Mourad, W
机构
[1] CHU Laval, Ctr Rech Rhumatol & Immunol, Dept Med, Quebec City, PQ G1V 4G2, Canada
[2] Univ Montreal, Fac Med, Dept Microbiol & Immunol, Lab Immunol Mol, Montreal, PQ H3C 3J7, Canada
关键词
D O I
10.1074/jbc.M211566200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid rafts are plasma membrane microdomains that are highly enriched in signaling molecules and that act as signal transduction platforms for many immune receptors. The involvement of these microdomains in HLA-DR-induced signaling is less well defined. We examined the constitutive presence of HLA-DR molecules in lipid rafts, their possible recruitment into these microdomains, and the role of these microdomains in HLA-DR-induced responses. We detected significant amounts of HLA-DR molecules in the lipid rafts of EBV+ and EBV- B cell lines, monocytic cell lines, transfected HeLa cells, tonsillar B cells, and human monocytes. Localization of HLA-DR in these microdomains was unaffected by the deletion of the cytoplasmic domain of both the a and beta chains. Ligation of HLA-DR with a bivalent, but not a monovalent, ligand resulted in rapid tyrosine phosphorylation of many substrates, especially Lyn, and activation of ERK1/2 MAP kinase. However, the treatment failed to induce further recruitment of HLA-DR molecules into lipid rafts. The HLA-DR-induced signaling events were accompanied by the induction of cell-cell adhesion that could be inhibited by PTK and Lyn but not ERK1/2 inhibitors. Disruption of lipid rafts by methyl-beta-cyclodextrin (MbetaCD) resulted in the loss of membrane raft association with HLA-DR molecules, inhibition of HLA-DR-mediated protein tyrosine phosphorylation and cell-cell adhesion. MbetaCD did not affect the activation of ERK1/2, which was absent from lipid rafts. These results indicate that although all the HLA-DR-induced events studied are dependent on HLA-DR dimerization, some require the presence of HLA-DR molecules in lipid rafts, whereas others do not.
引用
收藏
页码:7099 / 7107
页数:9
相关论文
共 50 条
[11]   Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR [J].
Dykstra, ML ;
Longnecker, R ;
Pierce, SK .
IMMUNITY, 2001, 14 (01) :57-67
[12]   Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates - II. A sequential lysis protocol for the analysis of tyrosine phosphorylation-dependent signalling [J].
Gilbert, C ;
Rollet-Labelle, E ;
Naccache, PH .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 261 (1-2) :85-101
[13]   THE CYTOPLASMIC AND TRANSMEMBRANE DOMAINS OF MHC CLASS-II BETA-CHAINS DELIVER DISTINCT SIGNALS REQUIRED FOR MHC CLASS II-MEDIATED B-CELL ACTIVATION [J].
HARTON, JA ;
VANHAGEN, AE ;
BISHOP, GA .
IMMUNITY, 1995, 3 (03) :349-358
[14]   Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts [J].
Huby, RDJ ;
Dearman, RJ ;
Kimber, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22591-22596
[15]   STAPHYLOCOCCAL-ENTEROTOXIN-A HAS 2 COOPERATIVE BINDING-SITES ON MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II [J].
HUDSON, KR ;
TIEDEMANN, RE ;
URBAN, RG ;
LOWE, SC ;
STROMINGER, JL ;
FRASER, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :711-720
[16]   Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane [J].
Ilangumaran, S ;
Hoessli, DC .
BIOCHEMICAL JOURNAL, 1998, 335 :433-440
[17]  
KANSAS GS, 1991, J IMMUNOL, V147, P4094
[18]   Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes [J].
Kropshofer, H ;
Spindeldreher, S ;
Röhn, TA ;
Platania, N ;
Grygar, C ;
Daniel, N ;
Wölp, A ;
Langen, H ;
Horejsi, V ;
Vogt, AB .
NATURE IMMUNOLOGY, 2002, 3 (01) :61-68
[19]   TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-α/β dimers [J].
Lang, P ;
Stolpa, JC ;
Freiberg, BA ;
Crawford, F ;
Kappler, J ;
Kupfer, A ;
Cambier, JC .
SCIENCE, 2001, 291 (5508) :1537-1540
[20]  
Langlois MA, 2000, EUR J IMMUNOL, V30, P1748, DOI 10.1002/1521-4141(200006)30:6<1748::AID-IMMU1748>3.0.CO